23 May 2013
Keywords: icn, sells, drug, rights, s-p, yugoslav, problems
Article | 22 July 1998
ICN Pharmaceuticals of the USA has sold its rights to co-market oralribavirin for the treatment of hepatitis C in the ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
22 July 1998
23 July 1998
22 May 2013
© 2013 thepharmaletter.com